Eterna Therapeutics renames to Ernexa Therapeutics Inc. effective March 26, 2025

Ernexa Therapeutics Inc.

Company changed its name from Eterna Therapeutics Inc. to Ernexa Therapeutics Inc.
Filed Certificate of Amendment to Restated Certificate of Incorporation with Delaware Secretary of State.
Adopted amended and restated bylaws solely to reflect the name change.
Effective date of name change: March 26, 2025.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.95

Ernexa Therapeutics Inc.: Adopted amended and restated bylaws solely to reflect the name change to Ernexa Therapeutics Inc (effective 2025-03-26).

Change: bylaw amendment
Effective: 2025-03-26

Exact text from the filing

effective March 26, 2025, the Company adopted amended and restated bylaws solely to reflect the Name Change.

View on SEC.gov

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.95

Ernexa Therapeutics Inc.: Amended Restated Certificate of Incorporation to change company name to Ernexa Therapeutics Inc (effective 2025-03-26).

Change: charter amendment
Effective: 2025-03-26

Exact text from the filing

effective March 26, 2025, Ernexa Therapeutics Inc. (formerly known as Eterna Therapeutics Inc.) (the “ Company ”), filed an amendment to the Company’s Restated Certificate of Incorporation, as amended with the Secretary of State of Delaware, to change the Company’s name to Ernexa Therapeutics Inc.

View on SEC.gov

Browse all governance changes →

Ernexa Therapeutics Inc. filing history →

Source: SEC EDGAR

accession 0001641172-25-000681

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.